Cargando…
MORPHEUS Phase II–III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results
SIMPLE SUMMARY: This prospective phase II–III randomized trial explores the value of modern technology for prudent radiation dose escalation in the curative management of patients with rectal cancer. It includes 40 operable patients with locally advanced operable rectal cancer. This manuscript illus...
Autores principales: | Garant, Aurelie, Vasilevsky, Carol-Ann, Boutros, Marylise, Khosrow-Khavar, Farzin, Kavan, Petr, Diec, Hugo, Des Groseilliers, Sylvain, Faria, Julio, Ferland, Emery, Pelsser, Vincent, Martin, André-Guy, Devic, Slobodan, Vuong, Te |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367346/ https://www.ncbi.nlm.nih.gov/pubmed/35954329 http://dx.doi.org/10.3390/cancers14153665 |
Ejemplares similares
-
A141 IS SURGERY STILL THE ONLY TREATMENT OPTION FOR CURABLE RECTAL CANCER?
por: Vuong, T, et al.
Publicado: (2022) -
The MORPHEUS protein crystallization screen
por: Gorrec, Fabrice
Publicado: (2009) -
The MORPHEUS II protein crystallization screen
por: Gorrec, Fabrice
Publicado: (2015) -
High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer
por: Vuong, Té, et al.
Publicado: (2015) -
Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation
por: Vuong, Te, et al.
Publicado: (2022)